SA
ABBV icon

Scarborough Advisors’s AbbVie ABBV Stock Holding History

Scarborough Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$372K Sell
1,632
-180
-10% -$38.7K 0.04% 115
2026
Q1 		$394K Buy
1,812
+78
+4% +$17.3K 0.04% 111
2025
Q4 		$396K Buy
1,734
+13
+0.8% +$2.96K 0.07% 70
2025
Q3 		$398K Buy
1,721
+14
+0.8% +$2.85K 0.07% 68
2025
Q2 		$317K Buy
1,707
+63
+4% +$11.7K 0.06% 72
2025
Q1 		$344K Buy
1,644
+74
+5% +$14.4K 0.05% 97
2024
Q4 		$279K Buy
1,570
+463
+42% +$85.1K 0.04% 101
2024
Q3 		$219K Buy
1,107
+4
+0.4% +$747 0.04% 81
2024
Q2 		$189K Buy
1,103
+12
+1% +$1.99K 0.08% 52
2024
Q1 		$199K Buy
1,091
+33
+3% +$5.69K 0.09% 47
2023
Q4 		$164K Buy
+1,058
New +$154K 0.03% 83

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Scarborough Advisors's ABBV Position: Q2 2026 in Review

Scarborough Advisors reduced its AbbVie (ABBV) stake by 9.9% in Q2 2026, selling an estimated $38.7K and leaving 1,632 shares worth $372K. The position accounts for 0.04% of the portfolio, ranked #115.

Scarborough Advisors first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $398K in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Scarborough Advisors held 1,632 shares of AbbVie worth $372K as of Q2 2026.
  • Scarborough Advisors sold 180 AbbVie shares in Q2 2026, an estimated $38.7K.
  • AbbVie made up 0.04% of Scarborough Advisors's portfolio in Q2 2026, its #115 holding.
  • Scarborough Advisors first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • Scarborough Advisors's AbbVie position peaked at $398K in Q3 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.